The Human Biome was established as a Medical University of Warsaw spin-off due to the commercialization of our scientific research. Initially at the University, then at the Human Biome, in close cooperation with academia, since 2014, we conduct research on the gut microbiome as a new type of biotherapeutic agent. Having very rich baggage of experience in hematology, transplantation, immunology, and microbiology, we have combined many fields of medicine and technology to enter the world of the microbiome and discover what is undiscovered.
HBI combines highly innovative microbiome knowledge and breakthrough technologies in one unique approach that is able to generate a pipeline of donor-independent New Generation Biotherapeutics (NGBs) as a Live Biotherapeutics Products (LBPs).
Technologies and microbiome products developed by HBI:
1. “MicroDrug®” - AI/ML-based in-silico and ultra-deep tech in-vitro lab composing Drug Discovery Platform to predict microbiota-based drugs:
- "Trapp MIcroBS" - in-silico computational platform predicting drug compositions
- “Q Lab” - highly innovative in-vitro laboratory applying microfluidic, genomic, culturomic and robotic technologies to synthesize New Generation Biotherapeutics.
2. Microbiome Biobank - over 20 000 samples collected to date, from unique donors and patients (triads) treated by in-house produced highly rich and viable microbiota transplant preparations (Mbiotix)
3. Fecal Microbiota Transplantation (FMT) Facility with Clinical Platform (HBI leads 8 clinical experiments based on FMT to discover context-oriented drug compositions)
4. “Mbiotix” - highest-quality FMT preparation delivered to over 1400 patients.
Currently, in the HBI pipeline are developed 4 New-Generation Biotherapeutics (NGB):
- anti-CDI NGB (anti Clostridioides difficile NGB)
- flagship anti-ARB/AI NGB (anti-antibiotic resistant bacteria and anti-infective NGB)
- immunobooster NGB (GvHD and immunooncology)
- longevity/wellbeing NGB.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Działkowa, Warszawa,mazowieckie 02-234,poland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- human-biome.com
- Keywords
- biotechnology, microbiome, live biotherapeutic products, drug discovery, immunology, infection, microbiome-based drugs, graft versus host disease, immunooncology.
- HQ
- Warszawa, Mazowieckie
Human Biome Sa Questions
Human Biome Sa's website is human-biome.com
Human Biome Sa's LinkedIn profile is https://pl.linkedin.com/company/human-biome-institute
Human Biome Sa has
22 employees.
View email and phone details for 22
employees at Human Biome Sa.
Human Biome Sa's industry is
Biotechnology Research
Human Biome Sa's top competitors are
Sano Centre For Computational Medicine,
Pikralida,
Iqrad,
Onebiome Sp. Z O.o.,
Urteste,
Genomtec Sa,
Wpd Pharmaceuticals Sp. Z O.o.,
Poltreg S.a.,
Molecure,
Ardigen.
Human Biome Sa's categories are Biotechnology Research
Human Biome Sa's founding year is 2019
